Topical nepafenac in the treatment of diabetic macular edema
David Callanan, Patrick WilliamsTexas Retina Associates, Arlington, TX, USAPurpose: To determine the safety and efficacy of topical nepafenac 0.1% in the treatment of diabetic macular edema.Methods: A consecutive case series was performed of patients treated with nepafenac monotherapy twice daily fo...
Enregistré dans:
Auteurs principaux: | David Callanan, Patrick Williams |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/abae7a7b616b4abd96dbec2d63fb594a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%
par: Seenu M Hariprasad, et autres
Publié: (2009) -
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
par: Singh R, et autres
Publié: (2012) -
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
par: Yüksel B, et autres
Publié: (2017) -
Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
par: Bruce I Gaynes, et autres
Publié: (2008) -
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
par: Dugel PU, et autres
Publié: (2015)